The inhibitory receptor LILRB4 (ILT3) modulates antigen presenting cell phenotype and, along with LILRB2 (ILT4), is upregulated in response to Salmonella infection

被引:51
|
作者
Brown, Damien P. [2 ]
Jones, Des C. [2 ]
Anderson, Katie J. [1 ]
Lapaque, Nicolas [2 ]
Buerki, Robin A. [2 ,3 ]
Trowsdale, John [2 ]
Allen, Rachel L. [1 ]
机构
[1] Univ London, Div Cellular & Mol Med, Ctr Infect, London, England
[2] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England
[3] Northwestern Univ, Evanston, IL USA
基金
英国惠康基金;
关键词
DENDRITIC CELLS; EXPRESSION; HYPORESPONSIVENESS; INTERLEUKIN-10; TOLERIZATION; INNATE; CANCER; MICE;
D O I
10.1186/1471-2172-10-56
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Leukocyte Ig-like receptors (LILR) are a family of innate immune receptors with immunomodulatory functions. High-level expression of the receptors LILRB2 (ILT4) and LILRB4 (ILT3) is a feature of tolerogenic antigen presenting cells and has been observed in cancer and transplant situations. There are relatively few studies regarding these receptors in the context of infection and it is not yet clear how LILRB4 exerts its inhibitory effects. Results: We studied the effects of LILRB4 ligation on antigen presenting cell phenotype, and the expression of LILRB2 and LILRB4 on Salmonella-infected antigen presenting cells. Ligation of LILRB4 throughout in vitro culture of dendritic cells led to an upregulation of the co-stimulatory protein CD86. Alterations in the production of IL-8 and IL-10 by LILRB4-ligated macrophages were also observed. Infection with Salmonella typhimurium or TLR stimulation with Salmonella components led to an upregulation of LILRB2 and LILRB4. Conclusion: Our results indicate that the inhibitory effects of LILRB4 do not result from a failure to upregulate co-stimulatory proteins. In addition to the high level expression that can render antigen presenting cells tolerogenic, there may be a role for lower level expression and activity of LILRB2 and LILRB4 in response to TLR signalling during an immune response to bacterial infection.
引用
收藏
页数:9
相关论文
共 25 条
  • [11] Analysis of the Expression and Function of Immunoglobulin-Like Transcript 4 (ILT4, LILRB2) in Dendritic Cells from Patients with Systemic Lupus Erythematosus
    Guerra-de Blas, Paola del Carmen
    Sebastian Villasenor-Talavera, Yael
    de Jesus Cruz-Gonzalez, Daniela
    Baranda, Lourdes
    Doniz-Padilla, Lesly
    Abud-Mendoza, Carlos
    Gonzalez-Amaro, Roberto
    Elizabeth Monsivais-Urenda, Adriana
    JOURNAL OF IMMUNOLOGY RESEARCH, 2016, 2016
  • [12] Crystal Structure of Leukocyte Ig-like Receptor LILRB4 (ILT3/LIR-5/CD85k) A MYELOID INHIBITORY RECEPTOR INVOLVED IN IMMUNE TOLERANCE
    Cheng, Hao
    Mohammed, Fiyaz
    Nam, Gol
    Chen, Yong
    Qi, Jianxun
    Garner, Lee I.
    Allen, Rachel L.
    Yan, Jinghua
    Willcox, Benjamin E.
    Gao, George F.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (20) : 18013 - 18025
  • [13] Blockade of checkpoint ILT3/LILRB4/gp49B binding to fibronectin ameliorates autoimmune disease in BXSB/Yaa mice
    Su, Mei-Tzu
    Inui, Masanori
    Wong, Yi Li
    Takahashi, Maika
    Sugahara-Tobinai, Akiko
    Ono, Karin
    Miyamoto, Shotaro
    Murakami, Keiichi
    Itoh-Nakadai, Ari
    Kezuka, Dai
    Itoi, So
    Endo, Shota
    Hirayasu, Kouyuki
    Arase, Hisashi
    Takai, Toshiyuki
    INTERNATIONAL IMMUNOLOGY, 2021, 33 (08) : 447 - 458
  • [14] Blockade of checkpoint ILT3/LILRB4/gp49B binding to fibronectin ameliorates autoimmune disease in BXSB/Yaa mice
    Su, Mei-Tzu
    Inui, Masanori
    Endo, Shota
    Takai, Toshiyuki
    JOURNAL OF IMMUNOLOGY, 2021, 206
  • [15] Myeloid immune checkpoint ILT3/LILRB4/gp49B can co-tether fibronectin with integrin on macrophages
    Itoi, So
    Takahashi, Naoyuki
    Saito, Haruka
    Miyata, Yusuke
    Su, Mei-Tzu
    Kezuka, Dai
    Itagaki, Fumika
    Endo, Shota
    Fujii, Hiroshi
    Harigae, Hideo
    Sakamoto, Yuzuru
    Takai, Toshiyuki
    INTERNATIONAL IMMUNOLOGY, 2022, 34 (08) : 435 - 444
  • [16] Rapamycin downregulates the inhibitory receptors ILT2, ILT3, ILT4 on human dendritic cells and yet induces T cell hyporesponsiveness independent of FoxP3 induction
    Fedoric, Boris
    Krishnan, Ravi
    IMMUNOLOGY LETTERS, 2008, 120 (1-2) : 49 - 56
  • [17] Fibronectin on target cells attenuates natural cytotoxicity of NK cells via myeloid immune checkpoint ILT3/LILRB4/gp49B
    Itagaki, Fumika
    Nakatsuka, Keita
    Sakai, Haruka
    Endo, Shota
    Su, Mei-Tzu
    Takai, Toshiyuki
    INTERNATIONAL IMMUNOLOGY, 2023, 35 (07) : 339 - 348
  • [18] Tolerogenic immunoreceptor ILT3/LILRB4 paradoxically marks pathogenic auto-antibody-producing plasmablasts and plasma cells in non-treated SLE
    Inui, Masanori
    Sugahara-Tobinai, Akiko
    Fujii, Hiroshi
    Itoh-Nakadai, Ari
    Fukuyama, Hidehiro
    Kurosaki, Tomohiro
    Ishii, Tomonori
    Harigae, Hideo
    Takai, Toshiyuki
    INTERNATIONAL IMMUNOLOGY, 2016, 28 (12) : 597 - 604
  • [19] IO-108, A fully human therapeutic antibody blocking the myeloid checkpoint LILRB2/ILT4, promotes innate and adaptive anti-cancer immunity in preclinical studies
    Ma, Jing-Tyan
    Liu, Xiaoye
    Stafford, Ryan
    McCutcheon, Krista
    Chen, Heyu
    Huang, Tao
    Tian, Hongyu
    Hong, Kyu
    Zhang, ChengCheng
    Chung, Luke
    Song, An
    Woodard, Paul
    Liao, XCharlene
    Costa, MariaJose
    CANCER RESEARCH, 2022, 82 (12)
  • [20] Expression of inhibitory receptors ILT3 and ILT4 on neoplastic B cells from patients with high-risk chronic lymphocytic leukemia: Implications for allogeneic stem cell transplantation.
    Colovai, Adriana I.
    Tsao, Lawrence
    Lin, Hana
    Fisher, Julie
    Bhagat, Govind
    Alobeid, Bachir
    Suciu-Foca, Nicole
    HUMAN IMMUNOLOGY, 2007, 68 : S111 - S111